Updated: January 27, 2026
Yusimry Drug Interactions: What to Avoid and What to Tell Your Doctor
Author
Peter Daggett

Summarize with AI
- Major Interactions: Avoid These Combinations
- Other Biologic DMARDs (Anakinra, Abatacept, Other TNF Blockers)
- Live and Live-Attenuated Vaccines
- Moderate Interactions: Monitor Carefully
- Rituximab (Rituxan) — Higher Infection Risk After Use
- CYP450 Substrates (Warfarin, Cyclosporine, Theophylline)
- Azathioprine and 6-Mercaptopurine (6-MP)
- Compatible Medications (Generally Safe to Continue)
- What to Tell Your Doctor
Learn the most important Yusimry (adalimumab-aqvh) drug interactions in 2026 — including medications, vaccines, and supplements to avoid or monitor carefully.
Yusimry (adalimumab-aqvh) interacts with a number of other medications, vaccines, and medical products. Some interactions are dangerous and must be avoided; others simply require closer monitoring. Because Yusimry suppresses part of your immune system, many interactions relate to increased infection risk. Here's what you and your doctor need to know.
Major Interactions: Avoid These Combinations
Other Biologic DMARDs (Anakinra, Abatacept, Other TNF Blockers)
Combining Yusimry with other biologic medications that also suppress the immune system is not recommended. Specifically:
Anakinra (Kineret): Combining anakinra (an IL-1 receptor antagonist) with a TNF blocker was associated with a greater proportion of serious infections and neutropenia, with no added benefit. This combination is not recommended.
Abatacept (Orencia): Concurrent use with TNF blockers including Yusimry was associated with more serious infections in RA trials, with no improvement in clinical benefit. Not recommended.
Other TNF blockers (etanercept, certolizumab, golimumab, infliximab): Combining multiple TNF blockers provides no additional benefit and significantly increases infection risk. Never use two TNF inhibitors simultaneously.
Live and Live-Attenuated Vaccines
You must NOT receive live or live-attenuated vaccines while on Yusimry. Because Yusimry suppresses the immune system, a live vaccine could cause infection instead of immunity. Live vaccines to avoid include:
MMR (measles, mumps, rubella)
Varicella (chickenpox)
Yellow fever
Live attenuated influenza vaccine (nasal spray flu vaccine — FluMist)
Non-live vaccines are generally safe on Yusimry: standard flu shot, COVID-19 vaccines, Shingrix (shingles), pneumococcal vaccines, and Tdap. Talk to your doctor about timing vaccines before starting Yusimry if possible.
Moderate Interactions: Monitor Carefully
Rituximab (Rituxan) — Higher Infection Risk After Use
A higher rate of serious infections has been observed in RA patients treated with rituximab who then receive a TNF blocker like Yusimry. If you have been on rituximab recently, your doctor should carefully consider the timing before starting Yusimry.
CYP450 Substrates (Warfarin, Cyclosporine, Theophylline)
TNF-alpha and other cytokines regulate liver enzymes called CYP450, which metabolize many medications. When TNF-alpha is blocked by Yusimry, CYP450 enzyme activity may change — altering how other drugs are processed. Drugs that are metabolized by CYP450 and have narrow therapeutic windows may need dose adjustment:
Warfarin (Coumadin): Monitor INR levels closely when starting or stopping Yusimry
Cyclosporine: Monitor blood levels and adjust dose as needed
Theophylline: Monitor drug concentrations — levels may change when starting or stopping Yusimry
Azathioprine and 6-Mercaptopurine (6-MP)
Azathioprine and 6-mercaptopurine are used in some IBD patients on Yusimry. While they can be continued if clinically necessary, this combination has been associated with hepatosplenic T-cell lymphoma (HSTCL) — a rare, aggressive, and often fatal T-cell cancer. HSTCL has primarily been reported in young adult males with Crohn's disease or ulcerative colitis. Discuss this risk carefully with your gastroenterologist.
Compatible Medications (Generally Safe to Continue)
Methotrexate — commonly used with Yusimry in RA; can improve efficacy and reduce antibody formation
Non-biologic DMARDs (hydroxychloroquine, sulfasalazine, leflunomide)
NSAIDs (ibuprofen, naproxen) — for pain management
Glucocorticoids (prednisone) — can be continued during Yusimry therapy (note: increases infection risk)
Aminosalicylates (mesalamine) — commonly continued in IBD patients on Yusimry
What to Tell Your Doctor
Before starting Yusimry, tell your doctor about all medications you take — including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements. Also share:
Any recent or planned vaccines (ask about timing before starting)
Any history of tuberculosis, hepatitis B, or opportunistic infections
If you are pregnant, plan to become pregnant, or are breastfeeding
Any blood thinners, immunosuppressants, or other biologic medications
For a complete overview of Yusimry side effects, see our guide: Yusimry Side Effects: What to Expect. And if you need help finding your prescription, medfinder can locate pharmacies near you with Yusimry in stock.
Frequently Asked Questions
Yes. Yusimry can be used alone or in combination with methotrexate and other non-biologic DMARDs. In rheumatoid arthritis, the combination of adalimumab + methotrexate is often more effective than either drug alone and may reduce the risk of developing antibodies against Yusimry.
Yes — the standard inactivated flu shot is safe to take with Yusimry. However, you must NOT get the live nasal spray flu vaccine (FluMist) while on Yusimry. Discuss timing of all vaccines with your doctor before starting Yusimry, since it's best to complete vaccinations before beginning immunosuppressive therapy.
Avoid: other biologic DMARDs (anakinra, abatacept, other TNF blockers) and live/live-attenuated vaccines (MMR, varicella, yellow fever, nasal flu vaccine). Use caution with CYP450 substrates like warfarin, cyclosporine, and theophylline — monitor drug levels when starting or stopping Yusimry.
Yes. NSAIDs like ibuprofen (Advil, Motrin) and naproxen (Aleve) can generally be continued while on Yusimry, and are commonly used for pain management in RA and other inflammatory conditions. Discuss with your doctor if you have GI, kidney, or cardiovascular concerns.
The safety of Yusimry during pregnancy is not fully established. Adalimumab crosses the placenta, and elevated levels have been found in exposed infants. If you are pregnant or planning to become pregnant, discuss the risks and benefits with your doctor. Live and live-attenuated vaccines should not be given to infants exposed to adalimumab in utero until confirmed safe by a pediatrician.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Yusimry also looked for:
More about Yusimry
30,682 have already found their meds with Medfinder.
Start your search today.





